Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03290482 · ClinicalTrials.gov registry record
Natural History of Eosinophilic Esophagitis
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 65
- Enrollment target
NCT03290482: Completed study, sponsored by Mayo Clinic.
NCT03290482 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03290482 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
Researchers are trying to understand the course of Eosinophilic Esophagitis (EoE), its progression and effects of treatments.
Primary Outcome
The number of recurrent symptoms using the modified Mayo Dysphagia Questionnaire (MDQ). The MDQ is a 32 - item instrument in which symptoms are divided into three symptom domains.
Interventions
- DIAGNOSTIC_TEST Barium Esophagram
- DEVICE EsophaCap
- DIAGNOSTIC_TEST Physical Examination and Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2017-06-19 |
| Est. Completion | 2020-03-25 |
What the finished NCT03290482 record still lists
NCT03290482 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Barium Esophagram is the first listed.
NCT03290482 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03290482 about?
NCT03290482 is a clinical study titled "Natural History of Eosinophilic Esophagitis". Researchers are trying to understand the course of Eosinophilic Esophagitis (EoE), its progression and effects of treatments.
What is the current status of trial NCT03290482?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2017-06-19. Estimated completion is 2020-03-25.
What interventions are being tested in trial NCT03290482?
The interventions under investigation include: Barium Esophagram (DIAGNOSTIC_TEST), EsophaCap (DEVICE), Physical Examination and Questionnaires (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03290482?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI